Latest Breaking News On - Novel microdevices - Page 2 : comparemela.com
The Baltimore Sun s 25 Women to Watch 2021: Best in advocacy, business and health
capitalgazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from capitalgazette.com Daily Mail and Mail on Sunday newspapers.
The Baltimore Sun s 25 Women to Watch 2021: Best in advocacy, business and health
baltimoresun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baltimoresun.com Daily Mail and Mail on Sunday newspapers.
CARB-X awards funding for rapid sexually transmitted infections test
CARB-X announced today that it is awarding up to $3.6 million in funding to Novel Microdevices, Inc. of Baltimore to develop a rapid, portable molecular diagnostic test for sexually transmitted bacterial infections.
Novel s rapid point-of-care test, which is in the early stages of development, would be able to diagnose
Neisseria gonorrhoea or
Chlamydia trachomatis infections in 25 minutes from a vaginal swab or urine sample, and detect genetic mutations that indicate resistance to antibiotics. The lightweight, battery-powered device is particularly suited to low-resource healthcare settings.
The device will be eligible for an additional $10.2 million from CARB-X (the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) if certain project milestones are met.
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience. Necessary
Novel Microdevices Joins Baltimore’s LaunchPort™ Medtech Venture Center
Share Article BALTIMORE (PRWEB) February 26, 2021 The LaunchPort™ announced today that Novel Microdevices (http://www.noveldx.com) has moved to their Medtech venture center in Port Covington, Baltimore, and has established The LaunchPort™ as its primary location for their GMP development efforts.
Novel Microdevices has established engineering prototyping, clean room operations, materials handling, and shop capabilities in separate modules within the Center that are allowing them to develop and validate the various elements of their Good Manufacturing Processes (GMP). The Company has received over $2M in NIH funding and is in the process of securing additional contracts for the delivery of diagnostics of sexually transmitted infections. The Company also recently received funding from NIH’s RADx program to explore the possible app
vimarsana © 2020. All Rights Reserved.